BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Kinarus presents plans for a drug against Long Covid

The drug Kin.001 is at the beginning of the clinical trial phase and will be on the market at the end of 2022, said CEO Alexander Bausch in a video report ...

June 02, 2021 | News

Novartis provides update on BEOVU clinical program

Novartis has also decided on early termination of the RAPTOR and RAVEN studies, which assessed the efficacy and safety of brolucizumab in retinal vein occl...

May 30, 2021 | News

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

May 31, 2021 | News

Merck,has launched a new, high-purity synthetic cholesterol product

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck, a leading science and technology company, has launched ...

May 26, 2021 | News

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

The goal is to assess the utility of combining Nanoform's nanoparticle platform technologies with Celanese's VitalDose® EVA copolymer delivery tec...

May 26, 2021 | News

Roche’s Antibody Cocktail now available in India

Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high...

May 24, 2021 | News

Gamma Biosciences Expand Reach in Gene Therapy & Vaccines

Lipid-polymer nanocomplexeHello News Desk,s (LPNCs) developed by Mirus enable superior transfection performance in a range of delivery applications Inve...

May 20, 2021 | News

Scientific studies by researchers in Singapore on the efficacy of COVID-19 mitigation measures

A*STAR has worked together with the local research ecosystem , including Temasek Foundation, Temasek Life Sciences Laboratory, Institutes of High...

May 18, 2021 | News

Sanofi and GSK COVID-19 vaccine shows strong immunity in all age variants

Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a ...

May 17, 2021 | News

IcanoMAB Announces a Novel IL-18 Signaling Blocker Treatment of the CR Syndrome

Positive regulatory advice received for development plan to provide POC in late-stage COVID-19 patients Additional opportunities in indications related ...

May 17, 2021 | News

COVAXIN® demonstrates protection against the new variants.

Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines...

May 16, 2021 | News

Terumo USD 1 Million Contributions will Help Bolster Vaccine Equity

As the world joins together to fight the ongoing battle against the COVID-19 pandemic, Terumo Corporation (TSE: 4543) has announced that the Terumo Group c...

May 14, 2021 | News

Phebra's Confirm Bioequivalence of Oral and IV Formulations

Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP43...

May 14, 2021 | News

Merck’s Focus on Cancer

Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program Merck (NYSE: MR...

May 13, 2021 | News

Stay Connected